London · Delayed Price · Currency is GBP · Price in GBX Elementis Earnings Call Transcripts
Fiscal Year 2025
-
Strong profit growth and margin expansion were achieved despite soft demand, driven by portfolio focus, cost savings, and innovation. The sale of non-core businesses and the Alchemy acquisition sharpened the specialty chemicals focus, with further growth and efficiency targeted for 2026.
-
Strong H1 performance with higher profits and margins, driven by cost savings, innovation, and the sale of the talc business. Specialty additives focus and new strategy set the stage for mid-single-digit growth and sector-leading margins, despite ongoing soft demand.
-
The sale of the Talc business for $121 million enables a strategic shift to high-margin specialty chemicals, improving margins and reducing leverage. Proceeds will fund a $50 million share buyback, with future growth focused on coatings and personal care through organic investment and selective bolt-ons.
Fiscal Year 2024
-
2024 saw revenue and profit growth driven by innovation, cost savings, and strong cash generation, with improved margins and reduced net debt. Despite flat demand, above-market growth was achieved in coatings and personal care, and the board is considering further shareholder returns.
-
Strong H1 results with 5% revenue and 24% operating profit growth, driven by innovation, efficiency, and robust performance in coatings and personal care. Strategic review of talc underway; 2024 guidance upgraded with $15 million cost savings expected.